MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis – JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib – Preliminary Data From the MANIFEST Study

This article has no abstract
Epistemonikos ID: b539180a23d6b429e73931a3ab6478a025576095
First added on: Feb 15, 2025